IL17A and Hepatic fibrosis: Recently, ILC3s have also been implicated in liver fibrosis as they enhance liver fibrosis by producing IL-22 and IL-17A when co-cultured with human HSC in vitro, and their secretion of IL-22 can block the anti-fibrotic effect of IFN-γ 13.